ADOPTIVE CELL THERAPY AGAINST TRIPLE-NEGATIVE BREAST CANCER USING A NOVEL TMUC1 ANTIBODY-DERIVED CAR

$1,110,546FY2018Defense Health AgencyDOD

University Of North Carolina At Charlotte, Charlotte NC

Investigators